Fig. 2From: Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapyROC curve of SUVmax of breast for predicting pCR after NAC: ROC curve demonstrating a pSUVmax of 9.55 as the optimal cutoff for predicting pCR (area under the curve: 0.703; standard error: 0.084), yielding a sensitivity of 87.5% and a specificity of 69.3%Back to article page